Arctic Bioscience AS (OSL:ABS) FFO


OSL:ABS Arctic Bioscience AS OSL:ABS
55 GF Score
Price kr3.19
GF Value kr10.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS FFO?

FFO (Funds from operations) only applies to REITs.

OSL:ABS
55GF Score
Arctic Bioscience AS OSL:ABS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.19 is trading 70% below its estimated GF Value™ of kr10.62. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • FFO:
  • GF Value™: kr10.62 vs. price of kr3.19 (70% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
55GF Score

Get the complete analysis for OSL:ABS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.19
Price
kr10.62
GF Value